Brand owners in the pharmaceutical sector are facing a challenge to find faster ways to launch brand protection measures. This challenge grows more complicated and time-consuming when pharma companies are managing brands across multiple jurisdictions.
World Trademark Review recently published an interview with INTA president-elect David Lossignol, Global Head of Trademarks at Sandoz International GmbH, where he manages the company's global trademark portfolio. Corsearch is a partner of Sandoz.
In the WTR interview, Lossignol compares managing trademarks in the pharmaceutical industry to the consumer goods sector because of the need "to be first to market" in a fast-moving business. He told WTR: " … you don’t always have as much time to test your marks before the trademark office and third parties during the opposition process, so you need to undertake robust searches in a shorter timeframe, and take smart risks."